BIOMARKERS

Molecular Biopsy of Human Tumors

Biomarkers for Uterine cancer

1. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. NR4A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. Beta-hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. MSH6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. PMS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. ARID1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. STK11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. CTNNB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. CYLD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. TSC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. MED12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. WFDC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. FGFR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. JAZF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. SUZ12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. PAX8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. ERBB3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. FES
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. HMGA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. SMARCB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. CASP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. MSN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. TOP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. RHOH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. CgA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. NFE2L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. SMARCA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. CIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. ETV5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. AKT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. CDC73
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. CLIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. PPP2R1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. RBM15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. CCNE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. DNMT3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. FLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. NUTM2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. PDGFRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. PIK3R1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. RAD51B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. TRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. REL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. SFRP4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. TFE3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. ARNT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. RUNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. STAT5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. ERBB4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. NDRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. DROSHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. MYOD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. SMO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. ERCC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. MALAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. NF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. PML
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. RECQL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. SALL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. SDHC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. SDHD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. ATRX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. ERCC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. FOXA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. IGH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. KAT6B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. NOTCH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. PMS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. CTCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. EBF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. EXT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. FANCD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. IL6ST
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. JAK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. NRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. NUTM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. SOCS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. CYP2D6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. AXIN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. AXIN2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. BCL9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. BCOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. BIRC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. COL1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. COL2A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. ETV4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. EZR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. HOXA9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. HOXD13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. NCOR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. PDCD1LG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. PIM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. TCF7L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. TRIM27
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. WIF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. ZNF198
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. HER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. Neurokinin
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. BRIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. ERG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. FLCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. FOXL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. HNF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. IDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. KEAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. MEN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. MPL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. NCOA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. NUTM2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. SBDS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. SPECC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. TBL1XR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. BCL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. BUB1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. HOXA11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. KMT2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. LMNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. MAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. MAP3K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. MUTYH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. NCOA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. PAX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. PCSK7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. PPM1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. SEPT5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. SH2B3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. STAT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. TET1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. TET2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. XPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. ZNF331
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. CCND2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. CD74
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. DAXX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. DNAJB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. ELL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. ERCC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. JAK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. KDM6A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. KLF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. LRIG3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. MALT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. MITF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. MYD88
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. NCOR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. PER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. PLAG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. PTK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. RPL22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. SFPQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. SND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. TCF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. TGFBR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
303. TPR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
304. U2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
305. WAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
306. WHSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
307. XPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
308. ZBTB16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
309. ACVR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
310. B2M
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
311. BCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
312. CACNA1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
313. CBL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
314. CDKN2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
315. CEBPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
316. CHD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
317. CREB3L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
318. DDX6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
319. DEK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
320. FGFR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
321. FOXP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
322. IDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
323. KLK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
324. KMT2D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
325. LCK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
326. LEF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
327. LPP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
328. LRP1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
329. MAML2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
330. MAP2K2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
331. MAP2K4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
332. POT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
333. PRDM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
334. SETBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
335. SPOP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
336. SRSF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
337. SSX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
338. TFRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
339. TRD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
340. WRN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
341. XPO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
342. CBFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
343. CCNB1IP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
344. CHIC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
345. CNBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
346. COX6C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
347. CRTC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
348. DDX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
349. FANCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
350. FCGR2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
351. FGFR1OP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
352. FLI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
353. GMPS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
354. GNA11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
355. GPC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
356. HEY1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
357. HNRNPA2B1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
358. HOXA13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
359. KDM5C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
360. KDSR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
361. LASP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
362. MLLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
363. MYCL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
364. NAB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
365. NUMA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
366. NUP214
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
367. PALB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
368. PICALM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
369. PPARG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
370. PTPN13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
371. QKI
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
372. RALGDS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
373. RNF43
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
374. SSX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
375. TBX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
376. TCL1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
377. TNFAIP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
378. TNFRSF17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
379. TOP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
380. TPM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
381. TSHR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
382. CEP17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
383. ALDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
384. APOBEC3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
385. ARHGAP26
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
386. ASPSCR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
387. ASXL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
388. BAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
389. BCL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
390. BMPR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
391. CANT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
392. CARD11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
393. CARS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
394. CASC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
395. CIITA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
396. CLP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
397. CREB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
398. DCTN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
399. DDB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
400. DDR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
401. DDX3X
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
402. DUX4L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
403. ELF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
404. EML4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
405. FANCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
406. FAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
407. FEV
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
408. FIP1L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
409. FOXO4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
410. FSTL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
411. FUBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
412. GATA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
413. H3F3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
414. HERPUD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
415. HLF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
416. HOXC11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
417. IGK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
418. IKBKB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
419. IKZF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
420. IL7R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
421. IRF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
422. KDM5A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
423. KIF5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
424. LCP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
425. LHFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
426. LIFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
427. LZTR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
428. MLLT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
429. MLLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
430. MN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
431. MSI2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
432. MYH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
433. MYO5A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
434. NFIB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
435. NONO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
436. PAX7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
437. PRCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
438. RAD21
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
439. RANBP2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
440. SDHAF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
441. SEPT9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
442. SF3B1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
443. SLC45A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
444. SMARCE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
445. SRSF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
446. SS18
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
447. SSX4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
448. SUFU
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
449. SYK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
450. TCF12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
451. TFEB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
452. TPM3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
453. TRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
454. TRIM24
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
455. USP6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
456. WWTR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
457. ZFHX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
458. Cytokeratin fragment 21-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
459. SET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
460. ABI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
461. ACKR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
462. ACSL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
463. ACSL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
464. ACVR2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
465. AFF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
466. AFF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
467. AFF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
468. AKAP9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
469. AMER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
470. ARHGEF12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
471. ARID2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
472. ATF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
473. ATIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
474. ATP1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
475. ATP2B3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
476. BCL11A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
477. BCL11B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
478. BCL5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
479. BCL7A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
480. BCL9L
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
481. BCORL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
482. BRD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
483. BTG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
484. BTK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
485. C12orf9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
486. C15orf65
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
487. C2orf44
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
488. CAMTA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
489. CBFA2T3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
490. CBLB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
491. CBLC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
492. CCND3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
493. CD79B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
494. CDK12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
495. CEP89
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
496. CHCHD7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
497. CLTC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
498. CLTCL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
499. CNOT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
500. CNTRL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
501. CREB3L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
502. CRLF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
503. CRTC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
504. CSF3R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
505. DDX10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
506. DNM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
507. ECT2L
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
508. EIF3E
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
509. EIF4A2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
510. ELK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
511. EPAS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
512. EPS15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
513. ERC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
514. ETNK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
515. ETV1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
516. EXT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
517. FAM131B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
518. FAM46C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
519. FANCE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
520. FANCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
521. FAT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
522. FBXO11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
523. FCRL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
524. FNBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
525. GAS7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
526. GATA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
527. GNAQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
528. GOLGA5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
529. GPHN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
530. GRIN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
531. H3F3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
532. HIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
533. HIST1H3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
534. HIST1H4I
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
535. HMGN2P46
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
536. HOOK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
537. HOXC13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
538. HOXD11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
539. HSP90AB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
540. IGL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
541. IL21R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
542. KAT6A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
543. KCNJ5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
544. KIAA1549
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
545. KIAA1598
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
546. KTN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
547. LMO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
548. LMO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
549. LSM14A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
550. LYL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
551. MAFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
552. MAP3K13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
553. MDS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
554. MECOM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
555. MKL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
556. MLF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
557. MLLT10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
558. MLLT11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
559. MLLT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
560. MNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
561. MTCP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
562. MYH9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
563. NACA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
564. NCOA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
565. NFATC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
566. NFKB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
567. NFKBIE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
568. NIN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
569. NSD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
570. NTRK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
571. NUP98
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
572. OLIG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
573. OMD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
574. P2RY8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
575. PAFAH1B2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
576. PAX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
577. PBRM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
578. PBX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
579. PCM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
580. PDE4DIP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
581. PHF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
582. PHOX2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
583. PLCG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
584. POU2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
585. PPP6C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
586. PRDM16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
587. PREX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
588. PRKACA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
589. PRRX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
590. PSIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
591. PTPRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
592. PTPRK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
593. PTPRT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
594. PWWP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
595. RABEP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
596. RANBP17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
597. RAP1GDS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
598. RBM10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
599. RMI2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
600. RNF213
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
601. RNF217-AS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
602. RPL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
603. RPL5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
604. RPN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
605. RSPO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
606. RSPO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
607. RUNDC2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
608. RUNX1T1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
609. SDC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
610. SEPT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
611. SETD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
612. SH3GL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
613. SLC34A2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
614. SMARCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
615. SRGAP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
616. SS18L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
617. STAG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
618. STRN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
619. TAF15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
620. TAL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
621. TCEA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
622. TCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
623. TFG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
624. TFPT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
625. THRAP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
626. TLX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
627. TLX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
628. TMEM127
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
629. TMPRSS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
630. TNFRSF14
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
631. TRAF7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
632. TRIM33
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
633. TRIP11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
634. TRRAP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
635. TTL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
636. UBR5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
637. USP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
638. VTI1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
639. WHSC1L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
640. ZCCHC8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
641. ZNF278
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
642. ZNF384
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
643. ZNF521
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
644. ZRSR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
645. IHC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
646. MAP-Tau mRNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
647. MK167
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
648. Nuclear matrix protein 22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
649. PAM50
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
650. CAD-ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
651. CD52
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]